These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3876397)

  • 1. Serum opsonic activity for Haemophilus influenzae type b in infants immunized with polysaccharide-protein conjugate vaccines.
    Cates KL
    J Infect Dis; 1985 Nov; 152(5):1076-7. PubMed ID: 3876397
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum opsonic activity after immunization of adults with Haemophilus influenzae type b-diphtheria toxoid conjugate vaccine.
    Cates KL; Marsh KH; Granoff DM
    Infect Immun; 1985 Apr; 48(1):183-9. PubMed ID: 3872263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of the immune response of infants to three Haemophilus influenzae type b vaccines.
    Turner RB; Cimino CO; Sullivan BJ
    Pediatr Infect Dis J; 1991 Feb; 10(2):108-12. PubMed ID: 2062600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b.
    Musher DM; Watson DA; Lepow ML; McVerry P; Hamill R; Baughn RE
    Pediatr Infect Dis J; 1988 Mar; 7(3):156-9. PubMed ID: 3258660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type B conjugate vaccines.
    Kaplan SL
    Pediatr Ann; 1990 Dec; 19(12):712-3, 716-8. PubMed ID: 2280990
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
    Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
    N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
    Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
    J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of anticapsular antibody after immunization with Haemophilus influenzae type b polysaccharide-diphtheria conjugate vaccine.
    Marchant CD; Band E; Froeschle JE; McVerry PH
    Pediatr Infect Dis J; 1989 Aug; 8(8):508-11. PubMed ID: 2788860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
    Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
    JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines.
    Granoff DM; Holmes SJ
    Vaccine; 1991 Jun; 9 Suppl():S30-4; discussion S42-3. PubMed ID: 1891954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of a Haemophilus influenzae type b polysaccharide-specific antibody response in human peripheral blood lymphocytes of individuals recently vaccinated with an oligosaccharide-protein conjugate.
    Peeters CC; Tenbergen-Meekes AM; Heijnen CJ; Poolman JT; Zegers BJ; Rijkers GT
    J Immunol; 1991 Dec; 147(12):4192-9. PubMed ID: 1753096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of Haemophilus influenzae type B polysaccharide-diphtheria toxoid conjugate vaccine in adults.
    Lepow ML; Samuelson JS; Gordon LK
    J Infect Dis; 1984 Sep; 150(3):402-6. PubMed ID: 6332863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemophilus influenzae type b vaccine.
    Anderson P; Pichichero ME
    Pediatrics; 1989 Jan; 83(1):145-6. PubMed ID: 2909967
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
    N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine.
    Mäkelä PH; Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.